Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Strong Dollar, Weak Performance: Big Pharma Is An Industry Adrift

This article was originally published in Scrip

Executive Summary

On the face of it, the latest quarterly results from the 10 biggest drug companies indicate that eight of them will have lower drug sales in 2015 than in 2014. The mood music behind the Q3 numbers is wistful and selective, suggesting that some of the biggest names in the industry are not sure where they are going even though they know that they don't really want to start from here.



Related Companies




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts